Zeinab Elsayed

503 total citations
21 papers, 335 citations indexed

About

Zeinab Elsayed is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Zeinab Elsayed has authored 21 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 5 papers in Surgery. Recurrent topics in Zeinab Elsayed's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Cancer Research and Treatments (2 papers). Zeinab Elsayed is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Cancer Research and Treatments (2 papers). Zeinab Elsayed collaborates with scholars based in Egypt, United States and Canada. Zeinab Elsayed's co-authors include Omar Abdel‐Rahman, Hesham Elhalawani, Joseph W. Landry, Tareq Saleh, Moureq R. Alotaibi, Hisashi Harada, Ajinkya S. Kawale, David A. Gewirtz, Graeme Murray and Jason Reed and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Zeinab Elsayed

17 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeinab Elsayed Egypt 8 110 101 99 80 75 21 335
Yung‐Bin Kuo Taiwan 11 133 1.2× 112 1.1× 81 0.8× 27 0.3× 34 0.5× 15 340
Maria Gonidi Greece 11 187 1.7× 146 1.4× 137 1.4× 43 0.5× 43 0.6× 29 466
Hongyan Zai China 11 144 1.3× 101 1.0× 61 0.6× 35 0.4× 71 0.9× 26 321
Thomas S. DeNapoli United States 6 116 1.1× 72 0.7× 35 0.4× 30 0.4× 33 0.4× 12 295
Hui Won Jang South Korea 12 80 0.7× 146 1.4× 124 1.3× 14 0.2× 108 1.4× 23 426
Mikiko Ida Japan 9 62 0.6× 89 0.9× 102 1.0× 28 0.3× 53 0.7× 17 335
Ge Lou China 9 161 1.5× 145 1.4× 66 0.7× 15 0.2× 29 0.4× 23 384
Jst Sham Hong Kong 8 109 1.0× 102 1.0× 110 1.1× 16 0.2× 169 2.3× 19 394
Mu Yan Cai China 7 115 1.0× 190 1.9× 57 0.6× 20 0.3× 33 0.4× 7 392

Countries citing papers authored by Zeinab Elsayed

Since Specialization
Citations

This map shows the geographic impact of Zeinab Elsayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeinab Elsayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeinab Elsayed more than expected).

Fields of papers citing papers by Zeinab Elsayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeinab Elsayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeinab Elsayed. The network helps show where Zeinab Elsayed may publish in the future.

Co-authorship network of co-authors of Zeinab Elsayed

This figure shows the co-authorship network connecting the top 25 collaborators of Zeinab Elsayed. A scholar is included among the top collaborators of Zeinab Elsayed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeinab Elsayed. Zeinab Elsayed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Elsayed, Zeinab. (2022). Glossary. 20(2). 97–97.
3.
Elsayed, Zeinab, et al.. (2022). Predictors of Survival of Patients with Cancer of Unknown Primary Site: A Retrospective Study from Two Institutions in Egypt. SHILAP Revista de lepidopterología. 0(0). 1–7. 1 indexed citations
5.
Abdel‐Rahman, Omar & Zeinab Elsayed. (2020). Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma. Cochrane Database of Systematic Reviews. 2021(10). 4 indexed citations
6.
Elsayed, Zeinab, et al.. (2020). Accelerated Hypofractionated Radiotherapy and Concurrent Etoposide/Cisplatin in Patients with Limited-Disease SCLC (LD-SCLC). Journal of Cancer Therapy. 11(11). 683–694. 1 indexed citations
7.
Abdel‐Rahman, Omar & Zeinab Elsayed. (2019). Immune checkpoint inhibitors for unresectable hepatocellular carcinoma. Cochrane Database of Systematic Reviews. 3 indexed citations
8.
Saleh, Tareq, Liliya Tyutyunyk‐Massey, Graeme Murray, et al.. (2018). Tumor cell escape from therapy-induced senescence. Biochemical Pharmacology. 162. 202–212. 128 indexed citations
9.
Elsebaie, Maha AT, Mohamed Amgad, Ahmed Elgebaly, et al.. (2018). Management of Low and Intermediate Risk Adult Rhabdomyosarcoma: A Pooled Survival Analysis of 553 Patients. Scientific Reports. 8(1). 9337–9337. 13 indexed citations
10.
Saleh, Tareq, Moureq R. Alotaibi, Ajinkya S. Kawale, et al.. (2018). Abstract 459: Therapy-induced senescence is reversible in vitro and in vivo. Cancer Research. 78(13_Supplement). 459–459. 1 indexed citations
11.
Abdel‐Rahman, Omar, et al.. (2018). Radical multimodality therapy for malignant pleural mesothelioma. Cochrane Database of Systematic Reviews. 2018(1). CD012605–CD012605. 19 indexed citations
12.
Abdel‐Rahman, Omar, Zeinab Elsayed, & Hesham Elhalawani. (2018). Gemcitabine-based chemotherapy for advanced biliary tract carcinomas. Cochrane Database of Systematic Reviews. 2018(4). CD011746–CD011746. 73 indexed citations
13.
Elsebaie, Maha AT & Zeinab Elsayed. (2017). Is fertility-preservation safe for adult non-metastatic gynecologic rhabdomyosarcoma patients? Systematic review and pooled survival analysis of 137 patients. Archives of Gynecology and Obstetrics. 297(3). 559–572. 10 indexed citations
14.
Elsayed, Zeinab, Michael R. Waters, Tana Blevins, et al.. (2017). BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands. Oncotarget. 8(38). 64344–64357. 27 indexed citations
15.
Abdel‐Rahman, Omar, et al.. (2017). Radical multimodality therapy for malignant pleural mesothelioma. Cochrane Database of Systematic Reviews. 10 indexed citations
16.
Elsayed, Zeinab, et al.. (2016). Preoperative Fasting Time and Selected Postoperative Outcomes among Patients Undergoing Abdominal Surgeries: Correlation Study. Journal of Health, Medicine and Nursing. 26. 109–119. 1 indexed citations
18.
Alorabi, Mohamed, et al.. (2016). Feasibility and reliability of the revised Edmonton Symptom Assessment System (ESAS-r) in Egyptian patients with advanced cancer: A single institutional experience. Oncology and Translational Medicine. 2(3). 132–137. 3 indexed citations
19.
Abdel‐Rahman, Omar & Zeinab Elsayed. (2016). Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma. Cochrane Database of Systematic Reviews. 11. CD011313–CD011313. 35 indexed citations
20.
Elsayed, Zeinab, et al.. (2016). Low-dose versus high dose radioactive iodine ablation differentiated thyroid carcinoma: a prospective randomized study.. Journal of Clinical Oncology. 34(15_suppl). 6087–6087. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026